Sheetal Parmar

🎥 Thrilled to officially launch our partnership with Good Heart Medical Group, Inc. in Santa Ana & Garden Grove, CA! Together, we’re addressing #obesity and #heart health—two major drivers of chronic disease—with a comprehensive, physician-led program. At Enara Health, we go beyond weight loss, helping patients build healthier habits through personalized nutrition, activity, and behavioral support. By combining our expertise, we’re preventing complications like #diabetes and #hypertension and empowering patients to achieve long-term health. This is the future of care—specialists and innovation transforming outcomes. 💙 #Healthcare #B2B #B2C #Health #PublicHealth #Cardiology #Obesity #Weight #Lifestyle #Habits #Partnership #Science #Program #WeightLoss #California #SantaAna #GardenGrove #Insurance #Ozempic #Wegovy #Mounjaro #Zepbound #Diet #Nutrition #Food #Activity #Exercise #Behavior #Medication #Medicine #Prevention #Future #Data

15

A new #CRISPR-based clinical trial for #SickleCell disease is enrolling at UCSF. This is the first therapy in the U.S. to apply non-viral CRISPR gene editing to directly correct the genetic mutation that causes the disease. Read more: https://ow.ly/Smry50UfZi1

32

🌟 Clinical Tips from the 20th Annual California Cancer Consortium Conference 2024 🌟 Reflecting on key takeaways from this year's conference, where experts shared groundbreaking insights in cancer research and treatment: 🔬 Expansion Cohorts in Early Phase Clinical Trials: Valuable or Not? 📝 How to Submit a Clinical Letter of Intent (LOI) to NCI/CTEP 🫁 Advances in Limited and Extensive Stage Small Cell Lung Cancer 💡 New Biomarkers in Breast Cancer ⚡ Novel Targets in Hematologic Malignancies These sessions highlighted cutting-edge advancements and strategies shaping the future of oncology. Excited to see where these innovations will lead! #CaliforniaCancerConsortium #CancerResearch #ClinicalTrials #SmallCellLungCancer #BreastCancer #HematologicMalignancies #Oncology #ClinicalTips #MedicalInnovation #NCI #CancerCare Primo Lara Timothy Synold Jonathan Riess Paul Frankel Percy Ivy Tycel Phillips

7

#PRIMR produces doctor-approved videos for trustworthy trial content. The RadiCaL Study is enrolling kidney cancer patients with bone metastases to explore if adding Ra-223 to cabozantinib improves patient outcomes. PI: Rana McKay UC San Diego Alliance for Clinical Trials in Oncology See IRB-approved video below 👇 https://lnkd.in/d97fj9dj #kidneycancer #kidneycancerawareness #cabozantinib #radium223 #radiopharmaceuticals #clinicaltrials #cancer #clinicalresearch #DEI #digital #health #immunotherapy #kidneycancer #men #menshealth #metastatickidneycancer #oncology #patienteducation #video #women #womenshealth #digital

1

Nearly a quarter-century ago, Bob Rosen recognized a critical gap in research when it came to a group of rare diseases, now known as myeloproliferative neoplasms (MPN).    His answer to this? Founding what is now known as the MPN Research Foundation.  Under Bob's leadership, and continuing after his passing in 2018, MPN Research Foundation has made significant strides: 👉We are a pioneering organization dedicated solely to funding MPN research. 👉We have invested over $18.8 million to support groundbreaking studies, leading to novel treatments with beneficial impact to patients and deeper understanding of disease progression. 👉Our funded research has aided in the critical discoveries such as the JAK2 and CALR mutations, among other milestones.  As we near what would have been Bob’s 81st birthday on May 6th, we are thrilled to announce a special match challenge. In honor of Bob’s vision, the Rosen family and friends will generously double every donation up to $35,000 to MPN Research Foundation throughout May, with a target of raising $100,000.   We invite our colleagues in the life sciences industry and research community to join us in this endeavor. Your support at this time is more than just a contribution—it’s a catalyst that will help us achieve and exceed our research goals, doubling the impact of each dollar donated toward pioneering new solutions for MPN patients.   Let’s continue to drive the legacy that Bob envisioned. Your engagement is crucial to sustaining momentum in MPN research. [ Donate Today and Double Your Impact! https://mpnrf.info/24mmli ]  Together, let's keep pushing forward, turning visionary research into tangible outcomes that honor Bob’s legacy and bring us closer to the cure he dreamed of.

37

2 Comments

Last year, Adhera Health presented the results of our preliminary study on the Adhera Caring Digital Program for family caregivers of children with type 1 diabetes at the American Diabetes Association's (ADA) 83rd Scientific Sessions in San Diego. The initial study showed significant reductions in stress levels and depression among caregivers using Adhera Caring. The final study indicated that caregiver wellbeing was significantly correlated with their children's wellbeing, underscoring the importance of considering the whole family unit when managing #peditricchronicconditions. The ADA event was an extremely valuable experience for Adhera Health, leading to a connection with Dr. Jennifer Raymond from Children’s Hospital LA. Dr. Raymond and her team in the Pediatric Endocrinology department at CHLA are now collaborating with Adhera Health on our The National Institutes of Health / National Institute on Minority Health and Health Disparities (NIMHD) - sponsored program to reduce health inequality for the U.S. Latinx population by adapting our Adhera Caring digital companion program for families dealing with pediatric chronic conditions such as Type 1 Diabetes, Obesity, and MS. We look forward to presenting the final findings of our NIH/NIMHD program at next year’s ADA. #AdheraHealth #DiabetesCare #CaregiverSupport #PediatricHealth #ChronicConditions #MentalHealth #FamilyWellbeing #HealthEquity #LatinxHealth #Type1Diabetes #Obesity #MultipleSclerosis #HealthcareInnovation #NIH #NIMHD #ADASCientificSessions #ChildrensHospitalLA #HealthTechnology #PatientCare #FamilyHealth

16

1 Comment

Are you attending the Sept. 25th San Francisco #AdvancedTherapiesXchange? Drawing on his 30+ years of experience leading immune cell operations, Kevin King, Senior Director of #CellandGeneTherapy Strategy and Growth at BioIVT, will be leading the 11:25am session “From Donor to Development: Minimizing Risks in the Cell Starting Materials Supply Chain” discussing strategies to de-risk the utilization of cellular starting and raw materials in the manufacture of #AdvancedTherapies: https://hubs.ly/Q02Qbz6B0 In the absence of industry-wide standardization of human cells, tissues, and cellular and tissue-based products (HCT/Ps), production and manufacturing processes are not equivalent among suppliers. This can create significant efficiency, quality and regulatory obstacles as therapeutic platforms transition from preclinical to clinical application. Kevin will also be joined by Lisa Kretzschmar, Senior Scientific Advisor for CGT at BioIVT, and Adam Ross, Technical Sales Specialist for CGT at BioIVT, for 1:1 meeting requests to discuss: - Why you need a partner that can take you from RUO to GMP - The value of having a geographically expansive, secure supply chain - The importance of donor diversity and its impact on your success - How BioIVT can support your CGT development, from discovery to clinical development Make sure to connect with our expert team if you’d like to schedule a meeting! Learn more about our CGT solutions: https://hubs.ly/Q02QbVwK0 #CellTherapy #GeneTherapy #ATMPs #hubXchange

14

The importance of an establishing an #RareDisease Advisory Council (#RDAC) can't be understated! Read the Managing Director of Care of The ALS Association in California's recent opinion piece to learn more: https://bit.ly/3Zf9jkJ #ALS #RareDisease #StatePolicy #California

7

Join Taylor Lipsich from PatientWing as she explores 'How Building Trust with Rare Disease Patients Accelerates Trial Enrollment' at the 20th Biopharma Clinical Trials Nexus in San Diego. Don't miss this insightful discussion! #NEXUSconference #Patientwing #BioPharmaNexus #raredisease

40

4 Comments

How to build a culture of innovation in the health sector? 🌟 Ashley Gambhir Executive Director of Transformation at UC San Diego Health explains how they use HYPE to bring together problem solvers that work to constantly do things better, improve the value of care they deliver to their patients. HYPE has become their innovation partner, helping to optimize their processes and deliver intended value. With ongoing support from the HYPE team, they learn, grow, and advance their innovation efforts. Check out their insights:

5